What is the recommended treatment algorithm for a posterior wall myocardial infarction?

Treatment Algorithm for Posterior Wall Myocardial Infarction

Posterior wall MI should be treated as a STEMI equivalent with immediate reperfusion therapy via primary PCI as the preferred strategy, following the same aggressive treatment protocols used for any ST-elevation myocardial infarction. 1

Initial Recognition and Diagnosis

ECG Identification

• Obtain a 15-lead ECG immediately (standard 12-lead plus posterior leads V7-V9) within 10 minutes of first medical contact, as posterior MI is frequently missed on standard 12-lead ECG 1
• Look for ST elevation ≥0.5 mm in leads V7-V9, which identifies acute posterior wall infarction with 97% sensitivity for posterior wall motion abnormalities 2, 3
• On standard 12-lead ECG, posterior MI presents as ST depression in leads V1-V3 (reciprocal changes), tall R waves in V1-V2, and upright T waves in anterior leads 2, 4
• The 15-lead ECG detects posterior ischemia in 74% of cases versus only 38% with standard 12-lead (p<0.0001) 3

Culprit Artery Prediction

• Posterior MI results from left circumflex artery (LCx) occlusion in most cases, though right coronary artery (RCA) can be involved in inferoposterior infarctions 5, 2
• ST depression in lead V2 has 100% positive predictive value for LCx obtuse marginal occlusion 6

Immediate Management (First Hour)

Monitoring and Supportive Care

• Establish ECG monitoring with defibrillator capacity immediately upon suspicion of STEMI 1
• Administer aspirin 150-300 mg orally or IV (if unable to swallow) as soon as possible unless contraindicated 1
• Oxygen is NOT recommended unless SaO2 <90% 1

Reperfusion Strategy Selection

Primary PCI is the preferred reperfusion strategy and must be performed within 90-120 minutes of first medical contact 1

Primary PCI Protocol:

• Transfer directly to catheterization laboratory, bypassing emergency department 1
• Administer potent P2Y12 inhibitor (ticagrelor or prasugrel preferred over clopidogrel) before or at time of PCI, continued for 12 months 1
• Anticoagulation with enoxaparin IV followed by subcutaneous (preferred over unfractionated heparin) or weight-adjusted UFH bolus and infusion 1
• Fondaparinux should NOT be used for primary PCI 1
• Stent placement (BMS or DES) is recommended during primary PCI 1
• Do NOT perform PCI on non-infarct arteries at time of primary PCI in hemodynamically stable patients 1

Fibrinolytic Therapy (If PCI Cannot Be Performed Timely):

• Initiate fibrinolysis within 12 hours of symptom onset if primary PCI cannot be performed within appropriate timeframe 1
• Use fibrin-specific agent (tenecteplase, alteplase, or reteplase) 1
• Aspirin plus clopidogrel for dual antiplatelet therapy 1
• Enoxaparin IV/SC preferred over UFH for anticoagulation, continued until revascularization or up to 8 days 1
• Transfer ALL patients to PCI-capable center immediately after fibrinolysis 1

Post-Fibrinolysis Management:

• Rescue PCI immediately if fibrinolysis fails (<50% ST resolution at 60-90 minutes) or with hemodynamic/electrical instability 1
• Angiography and PCI between 2-24 hours after successful fibrinolysis 1
• Emergency angiography for heart failure/shock or recurrent ischemia 1

Acute Phase Management (First 24-48 Hours)

Echocardiography

• Perform routine echocardiography during hospital stay to assess LV/RV function, detect mechanical complications, and exclude LV thrombus 1
• Posterior MI patients have 69% incidence of mitral regurgitation (moderate-severe in one-third), requiring specific assessment 2
• RV systolic dysfunction (RV systolic velocity <11.5 cm/s on tissue Doppler) occurs frequently with inferoposterior MI and significantly reduces exercise capacity 7

Medical Therapy Initiation

ACE Inhibitors:

• Start within first 24 hours in patients with heart failure, LV dysfunction (LVEF <40%), diabetes, or anterior infarct 1
• Use ARB (preferably valsartan) if ACE inhibitor intolerant 1

Beta-Blockers:

• Oral beta-blockers for patients with heart failure and/or LVEF <40% unless contraindicated 1
• AVOID IV beta-blockers in patients with hypotension, acute heart failure, AV block, or severe bradycardia 1

Statins:

• Start high-intensity statin therapy immediately and maintain long-term 1
• Target LDL-C <1.8 mmol/L (70 mg/dL) or ≥50% reduction if baseline 1.8-3.5 mmol/L 1

Long-Term Management (Post-Discharge)

Antiplatelet Therapy:

• Dual antiplatelet therapy (aspirin 75-100 mg plus ticagrelor or prasugrel) for 12 months unless excessive bleeding risk 1
• PPI recommended with DAPT in patients at high gastrointestinal bleeding risk 1
• Continue aspirin indefinitely after DAPT completion 1

Heart Failure Management:

• Mineralocorticoid receptor antagonist (MRA) for patients with LVEF <40% and heart failure or diabetes, already on ACE inhibitor and beta-blocker, without renal failure or hyperkalemia 1

ICD Consideration:

• ICD therapy recommended for symptomatic heart failure (NYHA II-III) with LVEF <35% despite optimal medical therapy for >3 months and ≥6 weeks post-MI 1

Cardiac Rehabilitation:

• Mandatory participation in cardiac rehabilitation program 1
• Aggressive smoking cessation with pharmacotherapy (nicotine replacement, varenicline, or bupropion) 1

Critical Pitfalls to Avoid

• Missing posterior MI on standard 12-lead ECG: Always obtain posterior leads V7-V9 when anterior ST depression is present with chest pain 2, 3
• Treating as NSTEMI instead of STEMI: Posterior MI with ST elevation in V7-V9 requires immediate reperfusion like any STEMI 2
• Performing multivessel PCI during primary procedure: This worsens outcomes in stable patients 1
• Using fondaparinux for primary PCI: This is contraindicated 1
• Routine oxygen administration: Only use if SaO2 <90% 1